Early research (Phase 1)Study completedNCT03085381What this trial is testingA Phase I Study of Quadrivalent HPV Recombinant VaccineWho this might be right forHPV Infections Shanghai Bovax Biotechnology Co., Ltd. 90
Large-scale testing (Phase 3)Study completedNCT00456807What this trial is testingComplementary Testing to Evaluate Immunogenicity of Human Papillomavirus (HPV) Vaccine (580299) in Healthy Female Subjects Aged >/= 26 YearsWho this might be right forInfections, Papillomavirus GlaxoSmithKline 100
Not applicableStudy completedNCT02551887What this trial is testingHPV Vaccination: An Investigation of Physician Reminders and Recommendation ScriptsWho this might be right forHuman Papilloma Virus Infection Type 11Human Papilloma Virus Infection Type 16Human Papilloma Virus Infection Type 18+4 more Regenstrief Institute, Inc. 647
Not applicableStudy completedNCT07521163What this trial is testingEffect of Health Belief Model-Based Education on Cervical Cancer Knowledge and HPV Vaccine Attitudes in WomenWho this might be right forCervical CancerHuman Papillomavirus InfectionPreventive Health Services Muhammet Faruk Yigit 154
Not applicableWithdrawnNCT03887793What this trial is testingQuality Improvement Strategies to Increase Human Papillomavirus (HPV) Vaccination in Integrated Healthcare Delivery SystemsWho this might be right forHuman Papillomavirus Infection University of North Carolina, Chapel Hill
Large-scale testing (Phase 3)Study completedNCT00380367What this trial is testingSafety, Tolerability and Immunogenicity of HPV (Human Papilloma Virus) Vaccine in Healthy Females 9 to 15 Years of Age in India (V501-029)Who this might be right forPapillomavirus Infections Merck Sharp & Dohme LLC 110
Not applicableStudy completedNCT07320157What this trial is testingThe Effect of HPV Education Provided to Women on Their Knowledge Levels, HPV Screening, and Vaccination UptakeWho this might be right forHPV (Human Papillomavirus)-AssociatedHPV Immunization Status Ufuk University 59
Large-scale testing (Phase 3)Active Not RecruitingNCT04199689What this trial is testingEfficacy Against Oral Persistent Infection, Immunogenicity and Safety of the 9-valent Human Papillomavirus Vaccine (9vHPV) in Men Aged 20-45 Years (V503-049)Who this might be right forPapillomavirus Infections Merck Sharp & Dohme LLC 6,033
Post-approval studies (Phase 4)UnknownNCT05279248What this trial is testingThe Immunogenicity and Safety of the Vaccination of Human Papillomavirus Vaccine and Measles-Mumps-Rubella VaccineWho this might be right forHuman Papilloma Virus Infection Type 16Human Papilloma Virus Infection Type 18Measles+2 more Zhejiang Provincial Center for Disease Control and Prevention 300
Not applicableActive Not RecruitingNCT05065840What this trial is testingAdvancing HPV Vaccination Among HIV Positive Adults: The CHAMPS StudyWho this might be right forHuman Papilloma VirusHuman Papilloma Virus Vaccine Emory University 267
Post-approval studies (Phase 4)Looking for participantsNCT05672927What this trial is testingComparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)Who this might be right forImmunizationHPV InfectionHuman Papillomavirus The University of Texas Medical Branch, Galveston 618
Post-approval studies (Phase 4)UnknownNCT05415345What this trial is testingImmunogenicity and Safety of Co-immunization With Cecolin and HecolinWho this might be right forHuman Papilloma Virus Infection Type 16Human Papilloma Virus Infection Type 18Hepatitis E Virus Infection Xiamen Innovax Biotech Co., Ltd 480
Large-scale testing (Phase 3)UnknownNCT01512784What this trial is testingLong Term Immunogenicity of Quadrivalent Human Papillomavirus Vaccine (Gardasil®)in HIV-infected Adolescents and Young AdultsWho this might be right forHPVHIV University of Milan 100
Post-approval studies (Phase 4)Active Not RecruitingNCT07281677What this trial is testingImmunogenicity and Safety of Sequential 2vHPV-9vHPV Vaccination in Girls Aged 9-14 YearsWho this might be right forHPV Infection Zhejiang Provincial Center for Disease Control and Prevention 400
Large-scale testing (Phase 3)UnknownNCT06207175What this trial is testingEvaluate the Immunogenicity and Safety of Nonavalent Human Papillomavirus (HPV) VaccineWho this might be right forHuman Papillomavirus Infection Beijing Health Guard Biotechnology, Inc 1,260
Not applicableStudy completedNCT03000998What this trial is testingWeb App Technology for Boys and Parents: Improving HPV Vaccine UptakeWho this might be right forHuman Papillomavirus VirusHPV Klein Buendel, Inc. 432
Post-approval studies (Phase 4)Study completedNCT00925288What this trial is testingAcceptability of Human Papillomavirus (HPV) Vaccine in Female Sex WorkersWho this might be right forHuman Papillomavirus Infection Johns Hopkins Bloomberg School of Public Health 200
Early research (Phase 1)UnknownNCT02888418What this trial is testingSafety and Immunogenicity Study of Human Papilloma Virus Vaccine in Women Aged 9 to 30 and Men Aged 9 to 17Who this might be right forCervical Cancer Beijing Chaoyang District Centre for Disease Control and Prevention 135
Large-scale testing (Phase 3)Study completedNCT00090220What this trial is testingEvaluate the Safety, Immune Response, and Efficacy of Gardasil (V501, qHPV) in Mid-Adult Women (V501-019)Who this might be right forHealthy Adult Female ParticipantsPreventionPapillomavirus Infection+1 more Merck Sharp & Dohme LLC 3,819
Large-scale testing (Phase 3)Study completedNCT02733068What this trial is testingA Phase III Study of Human Papillomavirus (HPV)-16/18 Vaccine.Who this might be right forHuman Papilloma Virus Infection Type 16Human Papilloma Virus Infection Type 18Cervical Intraepithelial Neoplasia Shanghai Zerun Biotechnology Co.,Ltd 12,000